Riociguat for the treatment of pulmonary hypertension
2011; Taylor & Francis; Volume: 20; Issue: 4 Linguagem: Inglês
10.1517/13543784.2011.565048
ISSN1744-7658
AutoresRalph T. Schermuly, Wiebke Janssen, Norbert Weißmann, Johannes‐Peter Stasch, Friedrich Grimminger, Hossein A. Ghofrani,
Tópico(s)Heart Failure Treatment and Management
ResumoIntroduction: Pulmonary hypertension (PH) is a severe condition with a poor prognosis despite recent treatment advances. Therapies with new mechanisms of action are needed.
Referência(s)